Cargando…
Jinlong capsule inhibits migration and invasion in human glioblastoma cells via the modulation of mTOR/S6 signaling pathway
Aim: To investigate the anticancer effects of Jinlong capsule (JLC) against human glioblastoma cells and the possible underlying mechanism. Methods: Cell Counting Kit-8 and colony formation assay were adopted for the analysis of cell viability. Cell invasion and migration were evaluated by transwell...
Autores principales: | Shi, Jingren, Zhang, Wenli, He, Lu, Kong, Fanhong, Pan, Meichen, Guo, Jingjing, Xu, Xinmin, Guo, Jie, Wang, Huizhu, Wang, Yajie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497872/ https://www.ncbi.nlm.nih.gov/pubmed/31114156 http://dx.doi.org/10.2147/DDDT.S195409 |
Ejemplares similares
-
Chinese patent medicine (Jinlong Capsule) for gastric cancer: Protocol for a systematic review and meta-analysis
por: Li, Jianwei, et al.
Publicado: (2020) -
Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis
por: Xu, He, et al.
Publicado: (2020) -
Trans-arterial chemoembolization combined with Jinlong capsule for advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis in a Chinese population
por: Jia, Shuzhao, et al.
Publicado: (2020) -
Emerging Gram-positive bacteria and drug resistance in cirrhosis patients with spontaneous bacterial peritonitis: A retrospective study
por: Guo, Jingjing, et al.
Publicado: (2019) -
EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)